The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACURX PHARMACEUTICALS INC PUT 00510M954   652,249 170,300 SH Put SOLE   170,300 0 0
ADMA BIOLOGICS INC COM 000899104   4,949,400 1,095,000 SH   SOLE   1,095,000 0 0
ADVISORSHARES TR PURE US CANNABIS 00768Y453   560,800 80,000 SH   SOLE   80,000 0 0
ALIMERA SCIENCES INC COM NEW 016259202   11,491,200 2,660,000 SH   SOLE   2,660,000 0 0
ALPINE IMMUNE SCIENCES INC COM 02083G100   1,500,460 78,723 SH   SOLE   78,723 0 0
AMYLYX PHARMACEUTICALS INC COM 03237H101   1,759,423 119,526 SH   SOLE   119,526 0 0
ARVINAS INC COM 04335A105   1,284,604 31,210 SH   SOLE   31,210 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101   3,148,750 25,000 SH   SOLE   25,000 0 0
ASTRIA THERAPEUTICS INC COM 04635X102   5,606,400 730,000 SH   SOLE   730,000 0 0
AXSOME THERAPEUTICS INC COM 05464T104   10,983,420 138,000 SH   SOLE   138,000 0 0
BIOXCEL THERAPEUTICS INC PUT 09075P955   499,140 169,200 SH Put SOLE   169,200 0 0
BITCOIN DEPOT INC *W EXP 06/30/202 09174P113   7,250 50,000 SH   SOLE   50,000 0 0
BRUUSH ORAL CARE INC *W EXP 08/03/202 11750K120   98 14,423 SH   SOLE   14,423 0 0
CASSAVA SCIENCES INC COM 14817C107   292,630 13,000 SH   SOLE   13,000 0 0
CASSAVA SCIENCES INC PUT 14817C957   1,057,970 47,000 SH Put SOLE   47,000 0 0
CATALYST PHARMACEUTICALS INC COM 14888U101   6,471,850 385,000 SH   SOLE   385,000 0 0
CEA INDUSTRIES INC *W EXP 02/11/202 86887P119   2,988 250,000 SH   SOLE   250,000 0 0
CINGULATE INC *W EXP 12/10/202 17248W113   8,100 270,000 SH   SOLE   270,000 0 0
COLISEUM ACQUISITION CORP *W EXP 08/22/202 G2263T107   1,133 28,333 SH   SOLE   28,333 0 0
CONDUIT PHARMACEUTICALS INC *W EXP 09/22/202 20678X114   6,930 100,000 SH   SOLE   100,000 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   2,312,700 65,000 SH   SOLE   65,000 0 0
CYCLACEL PHARMACEUTICALS INC COM NEW 23254L801   101,412 37,982 SH   SOLE   37,982 0 0
CYMABAY THERAPEUTICS INC COM 23257D103   2,621,820 111,000 SH   SOLE   111,000 0 0
CYTOKINETICS INC COM NEW 23282W605   1,669,800 20,000 SH   SOLE   20,000 0 0
DIAMEDICA THERAPEUTICS INC COM NEW 25253X207   817,062 287,698 SH   SOLE   287,698 0 0
DIGITAL HEALTH ACQUISITION C *W EXP 11/02/202 253893119   3,908 150,000 SH   SOLE   150,000 0 0
DOUBLEDOWN INTERACTIVE CO LT ADS 25862B109   447,408 60,876 SH   SOLE   60,876 0 0
EA SERIES TRUST ALPHA ARCH 1-3 02072L565   9,747,405 92,700 SH   SOLE   92,700 0 0
ENVVENO MEDICAL CORPORATION COM 29415J106   1,770,581 344,471 SH   SOLE   344,471 0 0
FAT BRANDS INC *W EXP 07/16/202 30258N121   680,000 200,000 SH   SOLE   200,000 0 0
FORTRESS BIOTECH INC COM NEW 34960Q307   1,219,417 405,122 SH   SOLE   405,122 0 0
IMMUNOVANT INC COM 45258J102   3,370,400 80,000 SH   SOLE   80,000 0 0
INSMED INC COM PAR $.01 457669307   3,718,800 120,000 SH   SOLE   120,000 0 0
INTRA-CELLULAR THERAPIES INC COM 46116X101   5,085,020 71,000 SH   SOLE   71,000 0 0
JEFFS BRANDS LTD *W EXP 08/26/202 M61472110   2,589 68,681 SH   SOLE   68,681 0 0
KARYOPHARM THERAPEUTICS INC COM 48576U106   640,100 740,000 SH   SOLE   740,000 0 0
MARINUS PHARMACEUTICALS INC COM NEW 56854Q200   2,174,000 200,000 SH   SOLE   200,000 0 0
MOBIX LABS INC *W EXP 12/21/202 60743G118   10,530 150,000 SH   SOLE   150,000 0 0
NEUROGENE INC COM 64135M105   1,298,092 66,981 SH   SOLE   66,981 0 0
NEXALIN TECHNOLOGY INC *W EXP 09/15/202 65345B110   924 105,000 SH   SOLE   105,000 0 0
NEXGEL INC *W EXP 12/01/202 65344E115   110,250 225,000 SH   SOLE   225,000 0 0
NLS PHARMACEUTICS LTD *W EXP 02/02/202 H57830111   11,220 200,000 SH   SOLE   200,000 0 0
NOCTURNE ACQUISITION CORP RIGHT 12/26/2025 G6580S106   82,400 500,000 SH   SOLE   500,000 0 0
NOVABAY PHARMACEUTICALS INC COM 66987P300   13,761 67,457 SH   SOLE   67,457 0 0
OLEMA PHARMACEUTICALS INC COM 68062P106   5,802,906 413,607 SH   SOLE   413,607 0 0
ONFOLIO HOLDINGS INC *W EXP 01/02/202 68277K124   16,000 200,000 SH   SOLE   200,000 0 0
ORIC PHARMACEUTICALS INC COM 68622P109   6,219,200 676,000 SH   SOLE   676,000 0 0
PEPPERLIME HEALTH ACQUSTN CO *W EXP 10/01/202 G70021111   11,062 367,500 SH   SOLE   367,500 0 0
PROSOMNUS INC *W EXP 04/20/202 50535E116   4,260 150,000 SH   SOLE   150,000 0 0
RELATIVITY ACQUISITION CORP *W EXP 12/15/202 75944B114   0 100,000 SH   SOLE   100,000 0 0
RHYTHM PHARMACEUTICALS INC COM 76243J105   298,115 6,485 SH   SOLE   6,485 0 0
SADOT GROUP INC COM 627333107   67,378 168,235 SH   SOLE   168,235 0 0
SAGIMET BIOSCIENCES INC COM SER A 786700104   2,531,634 483,181 SH   SOLE   483,181 0 0
SAVARA INC COM 805111101   6,265,100 1,333,000 SH   SOLE   1,333,000 0 0
SELINA HOSPITALITY PLC *W EXP 10/27/202 G8059B119   426 101,439 SH   SOLE   101,439 0 0
SOLENO THERAPEUTICS INC COM 834203309   4,222,587 104,909 SH   SOLE   104,909 0 0
SURROZEN INC *W EXP 08/01/203 86889P117   1,443 82,233 SH   SOLE   82,233 0 0
TC BIOPHARM HOLDINGS PLC *W EXP 02/10/202 87807D111   612 18,823 SH   SOLE   18,823 0 0
TG VENTURE ACQUISITION CORP *W EXP 08/15/202 87251T117   2,960 200,000 SH   SOLE   200,000 0 0
TONIX PHARMACEUTICALS HLDG C COM NEW 890260854   217,630 540,025 SH   SOLE   540,025 0 0
VERA THERAPEUTICS INC CL A 92337R101   9,458,700 615,000 SH   SOLE   615,000 0 0
VERU INC COM 92536C103   1,440,000 2,000,000 SH   SOLE   2,000,000 0 0
WEARABLE DEVICES LTD *W EXP 09/14/202 M97838110   98,812 1,411,600 SH   SOLE   1,411,600 0 0
WESTERN ACQSTN VENTURES CORP *W EXP 99/99/999 95758L115   3,190 100,000 SH   SOLE   100,000 0 0
XENON PHARMACEUTICALS INC COM 98420N105   13,382,042 290,535 SH   SOLE   290,535 0 0
XTANT MED HLDGS INC COM NEW 98420P308   9,071,180 8,027,593 SH   SOLE   8,027,593 0 0